Skip to content

Clinical trials

Terminated Carcinoma, Non-Small-Cell Lung trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Terminated Country / region: Taiwan Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20062
20075
20084
20092
20122
20131
20144
20155
20161
20172
20184
20199
20206
20216
20223
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated62

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals12
Pfizer7
AstraZeneca3
Clovis Oncology, Inc.3
Merck Sharp & Dohme LLC3
AbbVie2
Bayer2
BeiGene2
Blueprint Medicines Corporation2
GlaxoSmithKline2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung62
Neoplasms12
Neoplasm Metastasis10
Lung Neoplasms8
Melanoma7
Carcinoma5
Carcinoma, Renal Cell5
Squamous Cell Carcinoma of Head and Neck5
Triple Negative Breast Neoplasms4
Bronchial Neoplasms3

Trials

Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.